Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Friday, July 17, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Pharma
Pharma
Pharma
Takeda’s Zasocitinib Shows High Skin-Clearance Rates Across Hard-to-Treat Psoriasis Sites
Life Sciences Times
-
July 17, 2026
Pharma
Rectify Pharmaceuticals Names Constantine Chinoporos Executive Chairman
Life Sciences Times
-
July 16, 2026
Pharma
Keytruda Improves Progression-Free Survival in Phase 3 Endometrial Cancer Trial
Life Sciences Times
-
July 15, 2026
Pharma
Alkermes Reports Sustained Wakefulness Improvements With Alixorexton in Narcolepsy Study
Life Sciences Times
-
July 13, 2026
Pharma
EMD Serono Gets FDA Breakthrough Therapy Designation for Enpatoran in Lupus Patients
Life Sciences Times
-
July 8, 2026
Pharma
Innoviva Specialty Therapeutics Signs XACDURO Distribution and Licensing Deal With Dr. Reddy’s
Life Sciences Times
-
June 16, 2026
0
Pharma
Intellia Reports Additional Positive Phase 3 Results for Lonvo-Z in Hereditary Angioedema
Life Sciences Times
-
June 15, 2026
0
Pharma
Sumitomo Pharma America Presents New Clinical, Translational Data at EHA 2026
Life Sciences Times
-
June 15, 2026
0
Pharma
AstraZeneca Wins FDA Approval for TRUQAP Combination in Prostate Cancer
Life Sciences Times
-
June 15, 2026
0
Pharma
Alkermes Gets Orphan Drug Designations for Alixorexton in U.S., Europe
Life Sciences Times
-
June 15, 2026
0
Pharma
GENESIS Pharma Expands Alnylam Partnership to Nordic Region
Life Sciences Times
-
June 11, 2026
0
Pharma
Chiesi Completes Acquisition of KalVista Pharmaceuticals
Life Sciences Times
-
June 11, 2026
0
Pharma
Vertex Reports CASGEVY Data in Children Ages 5 to 11, Announces Additional Regulatory Submissions
Life Sciences Times
-
June 11, 2026
0
Pharma
Takeda Says Zasocitinib Outperformed Deucravacitinib in Phase 3 Psoriasis Study
Life Sciences Times
-
June 11, 2026
0
Pharma
PharmaEssentia Expands North American Presence With FORUS Therapeutics Acquisition
Life Sciences Times
-
June 11, 2026
0
Pharma
PharmaEssentia Wins Taiwan Approval for BESREMi in Essential Thrombocythemia
Life Sciences Times
-
June 10, 2026
0
Pharma
FDA Accepts Takeda Application for Pediatric ENTYVIO in Ulcerative Colitis and Crohn’s Disease
Life Sciences Times
-
June 10, 2026
0
1
2
3
...
96
Page 2 of 96
Most Read
Mirador Therapeutics Licenses Long-Acting Anti-C5a Antibody from Kira Pharmaceuticals
July 17, 2026
Bayer and Henry Ford Health Partner to Expand Patient Access to Clinical Trials
July 17, 2026
Inflammasome Therapeutics Reports Positive Phase 2 Results for K8 in Geographic Atrophy
July 17, 2026
Aqemia and Sanofi Expand AI-Driven Drug Discovery Collaboration
July 17, 2026